http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008004666-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bfddfc3596a36d5ae1d8e37b7943573d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-3962
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-3622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-39622
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-362
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-39
filingDate 2005-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75b340380832778c1febd4d1a1d555ad
publicationDate 2008-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2008004666-A1
titleOfInvention Device for Hemodynamic Stabilization During Tachycardias
abstract Implantable device, in particular implantable cardioverter-defibrillator, for responding to tachycardia events in a patient's heart comprising a control device, a first interface connected to said control device for receiving first signals representative of tachycardia events and connectable to a first sensor device for detecting tachycardia events, a second interface connected to said control device and connectable to a first stimulation electrode, and said control device being arranged for providing at least one stimulation pulse to said second interface in response to at least one of said first signals received at said second interface for responding to tachycardia events, wherein said control device is arranged for providing at least one first stimulation pulse to said second interface upon continued presence of said first signals at said first interface for at least intermittently improving the cardiac output during continued tachycardia events.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021202081-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009299205-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8280500-B2
priorityDate 2004-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004049235-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005070966-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5213098-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5243980-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005101998-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6442425-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127688846
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135843816
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128238201
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID447043
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2157
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406483

Total number of triples: 32.